Literature DB >> 8621012

Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment.

J Rincon1, A Holmäng, E O Wahlström, P Lönnroth, P Björntorp, J R Zierath, H Wallberg-Henriksson.   

Abstract

The absence of female sex hormones, as well as testosterone treatment of oophorectomized (OVX) female rats has been demonstrated to result in decreased whole-body insulin-mediated glucose uptake. The cellular mechanism behind this insulin resistance and the role of low levels of female sex hormones as a risk factor for development of peripheral insulin resistance are not yet fully clarified. We assessed the protein expression of GLUT4 and glycogen synthase, as well as insulin-induced translocation of GLUT4 to the plasma membrane, in soleus skeletal muscle from control rats, OVX rats, and OVX rats treated for 8 weeks with testosterone (OVX + T). Whole-body insulin-mediated glucose uptake assessed by the hyperinsulinemic-euglycemic clamp procedure was 25% lower in OVX rats (P < 0.001) and addition of testosterone treatment further decreased insulin-mediated glucose uptake in OVX + T rats by 48% (P < 0.001) compared with controls. GLUT4 protein expression in soleus muscles was unaltered in the OVX and OVX + T rats compared with controls. Insulin induced a 3.7-fold increase (P < 0.05) in the plasma membrane content of GLUT4 in soleus muscle from control rats, whereas plasma membrane content of GLUT4 in soleus muscle from OVX or OVX + T rats was unaltered in response to insulin. Glycogen synthase protein expression in muscle homogenates was decreased by 25% in the OVX group (P < 0.05) and by 37% in the OVX + T group (P < 0.05) when compared with the control group. Insulin receptor and tyrosine kinase activities in the basal and insulin-stimulated states did not differ between the OVX and OVX + T rats. In conclusion, the absence of female sex hormones appears to decrease insulin-mediated whole-body glucose uptake via an impaired insulin-stimulated translocation of GLUT4 to the plasma membrane and by decreased protein expression of glycogen synthase. Testosterone treatment further impairs whole-body insulin-mediated glucose uptake, presumably by additional impairment of glycogen synthase expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621012     DOI: 10.2337/diab.45.5.615

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  36 in total

Review 1.  Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment.

Authors:  B Andersson
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 2.  The ovarian androgen-producing cells: a 2001 perspective.

Authors:  Denis A Magoffin
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

3.  Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats.

Authors:  C Nilsson; M Niklasson; E Eriksson; P Björntorp; A Holmäng
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

4.  PET imaging reveals distinctive roles for different regional adipose tissue depots in systemic glucose metabolism in nonobese humans.

Authors:  Jason M Ng; Koichiro Azuma; Carol Kelley; Richard Pencek; Zofia Radikova; Charles Laymon; Julie Price; Bret H Goodpaster; David E Kelley
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-11       Impact factor: 4.310

5.  Risk of Diabetes After Hysterectomy With or Without Oophorectomy in Postmenopausal Women.

Authors:  Juhua Luo; JoAnn E Manson; Rachel Peragallo Urrutia; Michael Hendryx; Erin S LeBlanc; Karen L Margolis
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

Review 6.  Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome.

Authors:  C Chen; J Smothers; A Lange; J E Nestler; J F Strauss Iii; E P Wickham Iii
Journal:  Minerva Endocrinol       Date:  2010-12       Impact factor: 2.184

7.  Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal.

Authors:  Brian C Cooper; Cynthia K Sites; Peter R Casson; Michael J Toth
Journal:  Fertil Steril       Date:  2007-05       Impact factor: 7.329

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

9.  Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes.

Authors:  John R B Perry; Michael N Weedon; Claudia Langenberg; Anne U Jackson; Valeriya Lyssenko; Thomas Sparsø; Gudmar Thorleifsson; Harald Grallert; Luigi Ferrucci; Marcello Maggio; Giuseppe Paolisso; Mark Walker; Colin N A Palmer; Felicity Payne; Elizabeth Young; Christian Herder; Narisu Narisu; Mario A Morken; Lori L Bonnycastle; Katharine R Owen; Beverley Shields; Beatrice Knight; Amanda Bennett; Christopher J Groves; Aimo Ruokonen; Marjo Riitta Jarvelin; Ewan Pearson; Laura Pascoe; Ele Ferrannini; Stefan R Bornstein; Heather M Stringham; Laura J Scott; Johanna Kuusisto; Peter Nilsson; Malin Neptin; Anette P Gjesing; Charlotta Pisinger; Torsten Lauritzen; Annelli Sandbaek; Mike Sampson; Ele Zeggini; Cecilia M Lindgren; Valgerdur Steinthorsdottir; Unnur Thorsteinsdottir; Torben Hansen; Peter Schwarz; Thomas Illig; Markku Laakso; Kari Stefansson; Andrew D Morris; Leif Groop; Oluf Pedersen; Michael Boehnke; Inês Barroso; Nicholas J Wareham; Andrew T Hattersley; Mark I McCarthy; Timothy M Frayling
Journal:  Hum Mol Genet       Date:  2009-11-18       Impact factor: 6.150

10.  Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes--a potential model for PCOS-related insulin resistance.

Authors:  Michael C Allemand; Brian A Irving; Yan W Asmann; Katherine A Klaus; Laura Tatpati; Charles C Coddington; K Sreekumaran Nair
Journal:  PLoS One       Date:  2009-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.